News & Updates
Filter by Specialty:
Poor glycaemic control ups kidney function decline after DKD onset
Poor glycaemic control in patients with type 1 (T1D) or type 2 diabetes (T2D) contributes to a faster estimated glomerular filtration rate (eGFR) decline following diabetic kidney disease (DKD) onset, suggests a study. This association is more pronounced among those with severe albuminuria.
Poor glycaemic control ups kidney function decline after DKD onset
22 Jul 2024
Are bad dreams tied to cognitive decline, dementia in adults?
Having frequent distressing dreams may signal a higher risk of developing cognitive decline and dementia in adults, according to a prospective study of three population-based cohorts.
Are bad dreams tied to cognitive decline, dementia in adults?
22 Jul 2024
Can rosuvastatin protect against chemo-induced cardiotoxicity in HER2+ breast cancer?
Use of rosuvastatin is associated with a significantly lower decline in left ventricular ejection fraction (LVEF) and lower serum levels of cardiotoxicity-associated biomarkers in newly diagnosed HER2-positive breast cancer patients treated with anthracycline-based chemotherapy followed by trastuzumab, according to the results of a prospective, randomized, controlled, parallel study.
Can rosuvastatin protect against chemo-induced cardiotoxicity in HER2+ breast cancer?
22 Jul 2024
Melphalan-prednisone-bortezomib improves HRQoL in intermediate-fit and frail NDMM patients
Treatment with melphalan-prednisone-bortezomib (MPV) improves health-related quality of life (HRQoL) in both intermediate-fit and frail newly diagnosed multiple myeloma (NDMM) patients, according to the results of the prospective phase II HOVON123 trial.
Melphalan-prednisone-bortezomib improves HRQoL in intermediate-fit and frail NDMM patients
22 Jul 2024
Over-the-counter supplement touted for improving walking distance in PAD
Nicotinamide riboside supplements show a signal of benefit for helping patients with lower extremity peripheral arterial disease (PAD) walk more